RCUS CIK: 1724521

Arcus Biosciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−256
FY22:
438
FY23:
−306
FY24:
−170
FY25:
−482
Change from FY21 to FY25
millions USD
FY21:
−4.00
FY22:
−413
FY23:
194
FY24:
−84.0
FY25:
66.0
Change from FY21 to FY25
millions USD
FY21:
237
FY22:
33.0
FY23:
33.0
FY24:
277
FY25:
488
millions USD
FY21:
−23.0
FY22:
58.0
FY23:
−79.0
FY24:
23.0
FY25:
72.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−282
FY22:
432
FY23:
−330
FY24:
−176
FY25:
−484

All amounts in millions USD Data source:SEC EDGAR